Spravato treatment for Lantana — REMS-certified, insurance-covered TRD care.

For Lantana and Hypoluxo Island residents, RECO Integrated Psychiatry's Delray Beach office is the closest REMS-certified Spravato site — 18 minutes south on Federal Highway, less on A1A. The psychiatrist who evaluates you is the same clinician who manages your oral antidepressant and reviews PHQ-9 response across induction; there is no split between a ketamine clinic and an outside prescriber. Prior authorization runs before the first dosing session, and in-network coverage under Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS is confirmed in writing rather than promised verbally.

Lantana sits between Delray Beach and West Palm Beach — a compact coastal town whose barrier-island neighbors (Hypoluxo Island, Manalapan, Ocean Ridge) share the same practical problem when it comes to specialist psychiatric care: everything credible is either south in Broward or a long haul north. RECO Integrated Psychiatry’s Delray Beach office is 18 minutes down Federal Highway, faster on A1A, and delivers Spravato (esketamine) treatment under the FDA-mandated REMS protocol for treatment-resistant depression and depression with acute suicidal ideation. For a Lantana resident who has failed two or more oral antidepressants at adequate dose and duration, this is the nearest REMS-certified site with an in-house psychiatry team.

Spravato and the REMS protocol — what treatment actually looks like

Esketamine is delivered as a nasal spray that the client self-administers in the office under nursing supervision. Standard TRD induction dosing is 56 mg for the first session and 84 mg for every session thereafter, with downward adjustment for tolerability if a client experiences pronounced dissociation, sedation, or blood pressure elevation. Each nasal device delivers 28 mg — a 56 mg session uses two devices spaced five minutes apart, and an 84 mg session uses three.

Every session requires two hours of post-dose monitoring inside the office. Blood pressure is measured at baseline, at 40 minutes (the peak — transient systolic elevation of 15 to 20 mmHg is expected and does not require intervention unless it exceeds 180/110), and again before discharge. Dissociative symptoms are tracked with the CADSS, sedation with the MOAA/S, and any adverse event documented in the REMS registry. Clients cannot drive after a session; a ride home is confirmed before dosing begins. The REMS enrollment paperwork, session-level reporting, and specialty-pharmacy coordination are handled by the office — none of the federal registry work falls on the client.

The induction and maintenance schedule

For treatment-resistant major depressive disorder, induction is twice weekly for four weeks — eight sessions. Clients then move to weekly dosing for four weeks (four sessions), then to every-one-to-two-weeks maintenance guided by PHQ-9 response and functional recovery. For major depressive disorder with acute suicidal ideation, dosing is twice weekly for four weeks with a separate maintenance decision informed by ongoing psychiatric follow-up and, where relevant, active safety planning using the C-SSRS.

Most clients notice an initial shift in mood, anhedonia, or suicidal thinking within the first one to two weeks. Sustained response typically consolidates across the eight-session induction — meaningful PHQ-9 change is usually visible by session four or five. Non-responders (less than 50% PHQ-9 reduction by end of induction) are reassessed for augmentation, TMS, or a change of oral antidepressant rather than continued on an ineffective protocol. Discontinuation, when it happens, is done on a taper across weeks — abrupt cessation of a working antidepressant regimen carries a real relapse risk that a slower step-down avoids.

Spravato with an oral antidepressant, not instead of one

The FDA label for esketamine specifies use in conjunction with an oral antidepressant — Spravato is not a monotherapy. Clients who arrive on a partial-response SSRI (sertraline, escitalopram) or SNRI (venlafaxine, duloxetine) typically continue that agent through induction; the goal is to convert a partial response into a full response, not to swap medications mid-course. Clients who have failed multiple oral antidepressants may start or switch to a new agent at the same time as beginning esketamine, giving both the oral and the intranasal component time to reach effect.

Augmentation strategies — low-dose aripiprazole, quetiapine, lithium, or buspirone in selected cases — are considered in parallel where response is incomplete or where the diagnostic picture includes bipolar-spectrum features. RECO’s psychiatry team manages the concurrent oral regimen as part of the same treatment plan; there is no split between a “ketamine clinic” and an outside prescriber. Every session includes a brief psychiatric check on side effects, sleep, and interval mood, and the treating psychiatrist adjusts the oral component in real time rather than waiting for a follow-up weeks out.

Spravato versus IV ketamine — how we choose

Spravato is FDA-approved for TRD and MDD with suicidal ideation; IV ketamine remains off-label for depression and is typically cash-pay. Spravato dosing is fixed at 56 mg or 84 mg intranasally; IV ketamine is weight-based (commonly 0.5 mg/kg over 40 minutes) and allows response-based titration across an induction series. Both require roughly two hours in the office — Spravato because the REMS mandates it, IV ketamine because a 40-minute infusion plus recovery lands in the same window.

The choice is driven by insurance, prior treatment history, and comorbidity. A client with commercial coverage and documented TRD — two prior antidepressant failures at adequate dose and duration — is almost always steered to Spravato; the coverage, the FDA indication, and the REMS structure carry real clinical weight. A client who has already failed a Spravato induction, has an intolerance to intranasal administration, or presents with a comorbidity better suited to weight-based titration may be offered IV ketamine as a self-pay alternative. Both conversations happen at the initial psychiatric evaluation, not after the fact.

What to expect on your first visit from Lantana

The first visit is a full psychiatric evaluation with a RECO psychiatrist — not a sales consultation. History covers the depressive episode timeline, prior antidepressant trials (agent, dose, duration, response), bipolar and psychotic screening, substance use, and a review of medical comorbidities that matter for esketamine (uncontrolled hypertension, recent MI, aneurysmal vascular disease). Baseline PHQ-9 and GAD-7 are collected; the C-SSRS is used where suicidal ideation is active. The visit closes with a written treatment recommendation — Spravato, TMS, oral medication optimization, or a combination — and, if Spravato is indicated, a benefits check submitted the same day.

REMS enrollment and prior authorization typically resolve within three to seven business days for commercial plans. Once the specialty pharmacy ships the medication to the office, dosing sessions are scheduled at fixed times — most Lantana clients pick mid-morning or early-afternoon slots that let a family member handle the ride home without disrupting a full workday.

Insurance and admissions from Lantana

Spravato is in-network under Florida Blue, Aetna, Cigna, UnitedHealthcare, Humana, and BCBS commercial plans when TRD criteria are documented — two prior antidepressant failures at adequate dose (typically six weeks) and adequate duration without adequate response. Coverage details, out-of-pocket estimates, and prior-authorization status are confirmed in writing before the first dosing session, not after. RECO’s admissions team handles the payer-side paperwork; the client’s role is the clinical evaluation and the treatment itself.

The drive from Old Town Lantana or Hypoluxo Island runs 18 minutes on Federal Highway (US-1) south to Delray Beach; from Manalapan or Ocean Ridge, A1A along the coast is often faster and avoids Federal traffic. Same-week evaluations are usually available, and cancellations can create earlier slots — worth calling to check.

Serving residents of: Hypoluxo Island, Manalapan, Ocean Ridge, Old Town Lantana.